Photo of Elliot Rayfield

Elliot Rayfield

  • CLINICAL PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease
Print ProfilePrint Profile


  • Endocrinology

  • American Board of Internal Medicine


  • MD, Jefferson Medical College

  • Residency, Internal Medicine
    University of Michigan Hospitals

  • Fellowship, Endocrinology
    Harvard Medical School

  • Fellowship, Endocrinology
    Brigham and Women's Hospital


    Dr. Elliot Rayfield is a Clinical Professor of Medicine (Endocrinology, Diabetes, and Bone Diseases). Dr. Rayfield is Board Certified in Endcrinology and Metabolism.  His practice is centered on Types 1 and 2 Diabetes and Clinical Endocrinology. Dr. Rayfield serves as Chair of the Development Committee of the Endocrine Society and is on the Editorial Board of Endocrine Practice.   Dr. Rayfield is a Fellow of the American College of Clinical Endocrinology and a member of the American Diabetes Association.


  • 2009 -
    The Jacobi Medallion
    Mount Sinai Alumni Association

  • 1989 -
    First Professional Education Service Award
    American Diabetes Association, Downstate Affiliate, New York

  • 1985 -
    Fifth Annual Distinguished Research Award, Department of Medicine
    Mount Sinai Medical Center

  • 1975 - 1980
    NIH Research Career Development Award
    National Institutes of Health

  • 1975 - 1976
    American Diabetes Association Research and Development Award
    Mount Sinai Medical Center

  • 1967 -
    Alpha Omega Alpha
    Jefferson Medical College


LeRoith D, Rayfield E. The benefits of tight glycemic control in type 2 diabetes mellitus. Clinical Cornerstone 2007; 8(Suppl. 7): S19-S29.

Potenza M, Rayfield E. Targeting the Incretin System in Type 2 Diabetes. Mount Sinai Journal of Medicine 2009;.

Rayfield E. Evidence-Based Medicine-A Brief Review. Insulin 2010; 5: 7-10.

Magnotti M, Rayfield E. The HumaPenR Luxura TM HD Pen-- What Is the Role of 0.5-Unit Insulin Dosing? . Journal of Diabetes Science and Technology 2010 March; 4.

Rayfield E. Evidence-Based Medicine-GAPPNETTM and its Role in Patient Care. Insulin 2010; 5: 74-76.

Rayfield E. Clark T Sawin Library and Resource Center: An Update. Endocrine News 2010 September;.

Farkouh M, Rayfield E, Fuster V. Diabetes and Cardiovascular Disease. In: The Heart (Thirteenth Edition). pp2028-2058.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Rayfield is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


1150 Park Avenue
New York, NY 10128

Tel: 212-427-9191
Fax: 212-427-0855
Get Directions

Office Hours:
  • Monday 8:00am - 3:00pm
  • Tuesday 10:00am - 3:00pm
  • Wednesday 8:00am - 3:00pm
  • Thursday 10:00am - 3:00pm
  • Friday 8:00am - 3:00pm
Insurance Plans
  • Aetna U.S. Healthcare
  • CIGNA - Indemnity
  • Empire Blue Cross/Blue Shield
  • Medicaid
  • Medicare
  • Medicare Assignment
  • Metrahealth/United Health
  • Oxford Health Plans
  • PHS/Healthnet/Guardian
  • United Healthcare